Echocardiographic predictors of ventricular arrhythmias in patients with non-ischemic cardiomyopathy

Mehmet Harapoz; Matthew Zada; Jim Matthews; Saurabh Kumar; Liza Thomas

doi:10.1016/j.ijcha.2022.100962

Echocardiographic predictors of ventricular arrhythmias in patients with non-ischemic cardiomyopathy

Int J Cardiol Heart Vasc. 2022 Feb 4:39:100962. doi: 10.1016/j.ijcha.2022.100962. eCollection 2022 Apr.

Authors

Mehmet Harapoz^{1

2}, Matthew Zada^{1

2}, Jim Matthews³, Saurabh Kumar^{1

2

4}, Liza Thomas^{1

2

5}

Affiliations

¹ Department of Cardiology, Westmead Hospital, Sydney, NSW, Australia.
² Westmead Clinical School, University of Sydney, Sydney, NSW, Australia.
³ Sydney Informatics Hub, Core Research Facilities, University of Sydney, NSW, Australia.
⁴ Westmead Applied Research Centre, University of Sydney, Sydney, NSW, Australia.
⁵ South Western Sydney Clinical School, University of New South Wales, Sydney, NSW, Australia.

Abstract

Objective: Ventricular arrhythmias (VA) portend a poor prognosis in non-ischemic cardiomyopathy (NICM). In this meta-analysis we evaluated if left ventricular (LV) global longitudinal strain (GLS) and LV mechanical dispersion (LVMD) are associated with VA, specifically in NICM patients.

Methods: A systematic review and meta-analysis was performed to determine the predictive value of LV GLS and LVMD for VA in NICM patients. VA endpoints were a composite of sudden cardiac death, VA events (including ventricular tachycardia or ventricular fibrillation), cardiac arrest and appropriate implantable cardioverter-defibrillator (ICD) therapy. Hazard or odds ratios for univariate models were extracted for the relationship between LV GLS and LVMD with VA endpoints.

Results: A total of 984 patients from 6 published studies were included; 231 patients (23.5%) experienced the composite endpoint. NICM patients who experienced VA endpoints had LV GLS impairment compared to those without (weighted mean difference -1.93%; 95% confidence interval (CI) -2.77 to -1.10; p < 0.001) and LV GLS was related to VA endpoints (hazard ratio: 1.12, 95% CI 1.07-1.17, p < 0.001; odds ratio: 1.22, 95% CI 1.08-1.38, p = 0.002). Four studies reported mean LVMD (weighted mean -10.05 ms; 95% CI -28.25 to 8.14; p = 0.28), with 3 reporting risk ratios (1 reported odds ratio and 2 hazard ratios). Only odds ratio demonstrated statistical significance (hazard ratio: 0.47, 95% CI 0.01-22.25, p = 0.70; odds ratio: 1.59, 95% CI 1.14-2.22, p = 0.007).

Conclusion: LV GLS impairment demonstrates value for predicting VA endpoints in NICM patients. Inclusion of LV GLS may be appropriate in the surveillance, screening, and clinical management of NICM patients.

Keywords: Cardiomyopathy; Echocardiography; Myocardial Strain.